Log in to search using one of your social media accounts:

This page shows you the most recent publications within this specialty of the MedWorm directory.

Washington city sues Oxycontin maker for citizens' opioid problems
The city of Everett, Washington, is filing a lawsuit against Purdue Pharma, the maker of the painkiller Oxycontin, alleging the company supplied the drug to suspicious physicians and pharmacies, contributing to the growing epidemic of drugs in the community. Kenneth Craig reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 30, 2017 Category: Consumer Health News Source Type: news

In the battle against opioids, one city blames drug makers
Everett, Washington, is suing Purdue Pharma for "recklessly" supplying OxyContin to "suspicious" physicians and pharmacies (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 30, 2017 Category: Consumer Health News Source Type: news

Senator Probes Opioid Makers ' Role in U.S. Drug Abuse Epidemic
A U.S. senator wants information from the five top makers of opioid painkiller drugs in order to assess their role in the nation ' s opioid epidemic. Sen. Claire McCaskill wants to determine whether the five companies -- Purdue Pharma, Janssen... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 29, 2017 Category: Journals (General) Source Type: news

Olympus announces opening date for $12M Bartlett distribution center
Olympus' new $12 million dollar national service and distribution center in Bartlett Corporate Park will open this fall. The project, which will create 280 jobs, has a scheduled "operational date" of late September 2017 and a grand opening date sometime in February 2018, said Brian Spinosa, director of digital media at Olympus Corporation of the Americas. The facility will be the company's second national service c enter. The first location is located in San Jose, California. The new facility, expected… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: Elle Perry Source Type: news

U.S. Senator Launches Probe Into 5 Top Opioid Drugmakers
function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments.callee;setTimeout(function(){t(e,i)},0)}}(document.getElementById('vidible_1'),onPlayerReadyVidible); U.S. Democratic Senator Claire McCaskill sought on Tuesday details from the nation’s top opioid drugmakers on their ...
Source: Healthy Living - The Huffington Post - March 29, 2017 Category: Consumer Health News Source Type: news

How healthy is your county?
Southeastern Pennsylvania is home to both the healthiest and least healthy counties in Pennsylvania, according to a study released Wednesday. The eighth annual County Health Rankings report issued by the Robert Wood Johnson Foundation and the University of Wisconsin Population Health Institute looks at medical care and a variety of other factors — such as housing, education, jobs, access to healthy foods — when making it assessment. This year’s report also took a close look at premature deaths,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: John George Source Type: news

Former Eagles CB Lito Sheppard making play at Pa.'s new medical marijuana industry
Former Eagles cornerback Lito Sheppard is the latest entrepreneur with ties to Philadelphia sports teams to reveal his interest – both personally and professionally – in the medical marijuana industry. The ex-NFLer is the lead investor in Laso Therapeutics, which has applied for one of the state's medicinal marijuana/processor permits. “I feel very strongly about the benefits medical marijuana can have on individuals suffering from traumatic injuries and illnesses, which is why I have spearheaded… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: Alison Burdo Source Type: news

Dialysis clinic to move into Grand Avenue
Fresenius Medical Care plans to open a kidney dialysis clinic in The Shops of Grand Avenue in downtown Milwaukee. The clinic would be in the first floor of Grand Avenue’s west arcade, fronting on Second Street, according to plans filed with the city of Milwaukee. Construction is to start later this year to transform that area of the mall, and turn that first floor into a food hall and marketplace. The Fres enius clinic is another sign of the mall’s transformation away from its traditional retail… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: Sean Ryan Source Type: news

New Greensboro facility will house Triad Foot Center
Deep River Partners will break ground in the next two weeks on a two-story, 25,000-square-foot medical office building at 2001 N. Church St. in Greensboro that will be the new home of Triad Foot Center. Deep River partner Steve Shavitz said the 12,500-square-foot first floor had been leased to Cone Health for Triad Foot Center. Shavitz estimated the cost of the building, including outfitting, at around $5 million. Last week, Triad Business Journal reported that Triad Foot Center was expanding in to… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: John Brasier Source Type: news

CardioFocus(R) Completes $20 Million Equity Financing
MARLBOROUGH, Mass., March 29, 2017 -- (Healthcare Sales & Marketing Network) -- CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announce... Devices, Cardiology, Venture Capital CardioFocus, HeartLight, Endoscopic Ablation, atrial fibrillation, ablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2017 Category: Pharmaceuticals Source Type: news

Tyme Technologies Announces Two New Board of Director Appointments -- David Carberry and James Biehl
NEW YORK, March 29, 2017 -- (Healthcare Sales & Marketing Network) -- Tyme Technologies, Inc. (TYMI), a specialty biotechnology company developing cancer therapeutics targeted at multiple tumor types, today announced the addition of two new members to its ... Biopharmaceuticals, Oncology, Personnel Tyme Technologies, SM-88 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2017 Category: Pharmaceuticals Source Type: news

Lourdes' plan for Willingboro campus: Fill niche health needs
While still a community hospital at its core, Lourdes Medical Center of Burlington County has quietly transformed itself into also being a provider of a select array of specialty services — some on its own, some through collaborations with other health care organizations. “We are always looking at which services fit in our footprint and make sense for us to provide,” said Mark Nessel, executive vice president and COO of Lourdes Health System. The latest specialty addition at the Willingboro,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: John George Source Type: news

Burlco ‘hospital-within-a-hospital’ is rebranding
North Carolina-based Acuity Healthcare, which operates two long-term acute care [LTAC] hospitals in South Jersey and six overall, is rebranding its Burlington County site. Here are the details about its Willingboro LTAC, located inside Lourdes Medical Center of Burlington County: Old name: Lourdes Specialty Hospital of Southern New Jersey New Name: Acuity Specialty Hospital of Southern New Jersey. This new name becomes official in April. CEO: Monica Titus, who took over as CEO of the Willingboro… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: John George Source Type: news

​Mercy Health CEO helps open hospital in Caribbean
Mercy Health CEO John Starcher was among representatives of the Cincinnati-based system who helped open a medical center in Haiti this month. I previously reported that the nonprofit Mercy Health, which was known as Catholic Health Partners before rebranding in 2014, had made a $2 million grant to the Catholic Medical Mission Board to help build the 30-bed health cente r in Côtes-de-Fer. A grand opening was held March 20. Starcher and the others from Mercy joined area residents to tour the facility,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: Barrett J. Brunsman Source Type: news

New analysis: More than half of patients ’ out-of-pocket spending for brand medicines is based on full list price
More than half of commercially insured patients ’ out-of-pocket spending for brand medicines is based on full list prices, according to anew analysis from Amundsen Consulting, a division of QuintilesIMS. Even though rebates paid by biopharmaceutical companies can substantially reduce the prices insurers and pharmacy benefit managers (PBMs) pay for brand medicines, insurers use list prices —rather than discounted prices—to determine how much to charge patients with deductibles and coinsurance. The newly released data show cost sharing for nearly one in five brand prescriptions filled in the commercial market is based ...
Source: The Catalyst - March 29, 2017 Category: Pharmaceuticals Tags: drug cost out of pocket costs Value-Driven Health Care Source Type: news

Girls Badly Burned By The Viral Homemade Slime Experiment Reveals Hidden Dangers
Middle school girls in Massachusetts and the UK are badly burned performing a homemade demonstration of a polymer. The lessons: 1) Use borax dissolved in water, not the straight powder, 2) wash your hands extensively after handling slime, 3) use more glue than borax, 4) wash your hands, everytime! (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2017 Category: Pharmaceuticals Authors: David Kroll, Contributor Source Type: news

Cleveland Clinic wants ability to remove conditions treated in Ohio medical marijuana program
The No. 2 hospital in the nation wants a way to remove or modify the conditions that qualify patients for medical marijuana in Ohio. Draft rules allow for advocates to petition for new diseases to join the list of 20 qualifying conditions but not a way to remove or modify already-approved conditions. The Cleveland Clinic would like to change that, and asked the State Medical Board of Ohio to include a process to do so. “It is almost certain that the list of conditions for which marijuana can… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: Tom Knox Source Type: news

L.A. billionaire by far the largest donor to San Jose flood-relief efforts
In the month since floods devastated several San Jose neighborhoods, dozens of businesses in the region have opened their wallets to aid recovery efforts, but some of Silicon Valley's largest employers — among them, Apple, Applied Materials, Nvidia, Google, Oracle and Facebook — appear not to have donated a dime to the primary relief fund. As a counter to those companies that did not contribute, more than 70 businesses and organizations gave something to aid those affected by Feb. 21 floods… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: Jennifer Elias Source Type: news

Tepha Inc. Subsidiary, Galatea Surgical, Announces Launch of GalaSHAPE(TM) 3D Surgical Scaffold
LEXINGTON, Mass., March 29, 2017 -- (Healthcare Sales & Marketing Network) -- Galatea Surgical, a wholly owned subsidiary of Tepha Inc., announced today the launch of its GalaSHAPE™ 3D Surgical Scaffold ("GalaSHAPE 3D") for use in aesthetic plas... Devices, Surgery, Product Launch Galatea Surgical, Tepha Inc, GalaSHAPE 3D, Surgical Scaffold (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2017 Category: Pharmaceuticals Source Type: news

Sonoma Pharmaceuticals Receives U.S. FDA Clearance of Loyon(R) Skin Descaler for Relief of Scaling Associated with Various Dermatoses
PETALUMA, Calif., March 29, 2017 -- (Healthcare Sales & Marketing Network) -- Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of derm... Biopharmaceuticals, Dermatology, FDA Sonoma Pharmaceuticals, Loyon Skin Descaler, dermatoses (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2017 Category: Pharmaceuticals Source Type: news

Evaluating API and Excipient Characteristics for Tablet Formulations
Before tablet formulations are designed, any active pharmaceutical ingredients (API) and excipients should be fully understood in terms of their compressibility, compactability, and manufacturability. (Source: Drug Development Technology)
Source: Drug Development Technology - March 29, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves Genentech’s OCREVUS(TM) (Ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) approved OCREVUS™ (ocrelizumab) as the first and only... Biopharmaceuticals, Neurology, FDA Genentech, Roche Group, OCREVUS, ocrelizumab, multiple sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2017 Category: Pharmaceuticals Source Type: news

FDA approves Roche's OCREVUS ™ (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) approved OCREVUS™ (ocrelizumab) as the first and only medicine for both relapsing and primary progressive forms of multiple sclerosis. The majority of people with MS have a relapsing form or primary progressive MS at diagnosis. (Source: World Pharma News)
Source: World Pharma News - March 29, 2017 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

What Good Population Health Means To Your Paycheck
Healthier populations " tend to have faster job growth, population growth and income growth, ” a new report from Blue Cross and Blue Shield Association and Moody ' s Analytics said. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2017 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NYSE:UNH NYSE:CI NYSE:AET NYSE:WLP Source Type: news

Mankind Pharma mulls to invest Rs 305-crore in Pathkind Diagnostics
"We are foraying into diagnostics space with new venture Pathkind Diagnostics. In the coming 4 years, the company has a plan to invest Rs 305 crore in its new venture, which will start its operation from August 2017," a company statement said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 29, 2017 Category: Pharmaceuticals Source Type: news

Text While Driving, Pay...$10,000? Why Draconian Punishments Don ' t Work
In Alaska, until recently, texting while driving could result in a $10,000 fine and a year in prison for a first offense -- even though research suggests harsh punishments don ' t stop impaired driving. Why don ' t more states and courts use strategies that will? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2017 Category: Pharmaceuticals Authors: Diana Hembree, Contributor Source Type: news

How to get adults to eat their vegetables? Study explores potential of spices and herbs use
According to recent reports, most Americans, of all ages and genders, do not meet the recommended vegetable intake of 2 to 3.5 cups per day, consuming an average of only 1.5 cups per day. Although tactics such as providing vegetables as a juice or hidden as a puree in entrees have been suggested, many people still say no thanks to vegetables, citing adverse taste perception. (Source: World Pharma News)
Source: World Pharma News - March 29, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Active Partners in Research
As companies increasingly integrate patient input into their R&D activities, they are coming to realize that they must also forge strong partnerships with patients and their families if they are to deliver truly patient-centered care. Yet, how do you transform buzzwords like patient engagement, patient voices, patient partnerships from theory into practice?It starts with being more systematic, says Danielle Gerlag, Patient Engagement Lead at  GlaxoSmithKline. “Over the last 10-15 years, we’ve done a lot to get the patient’s voice heard within GSK and there are pockets of excellence where we have engaged with pat...
Source: EyeForPharma - March 29, 2017 Category: Pharmaceuticals Authors: Deirdre Coleman Source Type: news

Neurological diseases cost the US nearly $800 billion per year
A new paper published in the Annals of Neurology reports the most common neurological diseases pose a serious annual financial burden for the nation. The report notes that the current estimated annual cost to American society of just nine of the most common neurological diseases is staggering, totaling $789 billion in 2014 dollars. These conditions include Alzheimer's disease and other dementias, low back pain, stroke, traumatic brain injury, migraine, epilepsy, multiple sclerosis, spinal cord injury, and Parkinson's disease. (Source: World Pharma News)
Source: World Pharma News - March 29, 2017 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

University of Hawaii, Cardax say study shows anti-aging potential
The University of Hawaii ’s John A. Burns School of Medicine and Honolulu-based life sciences company Cardax Inc. have announced the results of an animal study evaluating the effectiveness of the naturally-occurring chemical astaxanthin that holds promise in anti-aging therapy. The astaxanthin compound CDX-085, developed by Cardax (Other OTC:CDXI), has shown the ability to significantly increase the expression of the FOX03 gene, which plays a proven role in longevity. Astaxanthin is a naturally… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 29, 2017 Category: Pharmaceuticals Authors: HJ Mai Source Type: news

CtW Investment Calls for Governance Changes at Universal Health Services
An adviser to pension funds invested in hospital company Universal Health Services said it will oppose reelection of a UHS director unless the company promises to overhaul its governance. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

FDA approves Roche ’s OCREVUS™ (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Roche announced today that the US Food and Drug Administration (FDA) approved OCREVUS ™ (ocrelizumab) as the first and only medicine for both relapsing and primary progressive forms of multiple sclerosis. (Source: Roche Media News)
Source: Roche Media News - March 29, 2017 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s OCREVUS™ (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Roche announced today that the US Food and Drug Administration (FDA) approved OCREVUS ™ (ocrelizumab) as the first and only medicine for both relapsing and primary progressive forms of multiple sclerosis. (Source: Roche Investor Update)
Source: Roche Investor Update - March 29, 2017 Category: Pharmaceuticals Source Type: news

UREA NAIL (Urea) Gel [H2-Pharma, LLC]
Updated Date: Mar 29, 2017 EST (Source: DailyMed Drug Label Updates)
Source: DailyMed Drug Label Updates - March 29, 2017 Category: Drugs & Pharmacology Source Type: news

FDA Approves Drug for Primary Progressive Multiple Sclerosis
The FDA approved a Genentech multiple-sclerosis drug called Ocrevus, the first treatment for the most severe type of MS. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Just When Does A Sleepless Night Become A Sleep Disorder?
Americans need sleep more than ever. And it seems like older adults in the states suffer the most. But what exactly constitutes a sleep disorder and what are some new sleep tricks that are still teachable to a, well, older person? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2017 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

Could Losing Sleep Be Killing You?
Sleep experts agree that chronic poor sleep in general and obstructive sleep apnea in particular (OSA) in anyone, but especially in older adults, can be fatal. They say they ' re heartbreaking, literally. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 29, 2017 Category: Pharmaceuticals Authors: Robin Seaton Jefferson, Contributor Source Type: news

FDA Approves Regeneron and Sanofi's Dupixent for Eczema
Regeneron Pharmaceuticals and Sanofi said they will charge $37,000 annually in the U.S. for their newly approved eczema drug, a price the companies said they reached after months of negotiations with pharmacy benefit managers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news

More States Weigh Expanding Medicaid After GOP Health Bill's Demise
A growing number of states are considering expanding their Medicaid programs under the Affordable Care Act, after last week ’s abrupt collapse of the GOP health bill and a development that could make it harder for Republicans to undo the law in the future. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Vertex hails new cystic fibrosis drug
Combination treatment offers safer option for patients suffering from deadly illness (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 29, 2017 Category: Pharmaceuticals Source Type: news

Kansas GOP-Led Legislature Approves Medicaid Expansion
Lawmakers voted to extend Medicaid to cover more than 150,000 additional nondisabled adults under the Affordable Care Act, just days after Republicans in Washington pulled their bill to repeal and replace the law known as Obamacare. (Source: WSJ.com: Health)
Source: WSJ.com: Health - March 29, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news

Leading Thyroid Pharmacist Announces the Launch of The Thyroid Secret
Thyroid Pharmacist, Dr. Isabella Wentz, Pharm.D., FASCP, launched the 9-part documentary series titled The Thyroid Secret.(PRWeb March 29, 2017)Read the full story at http://www.prweb.com/releases/Dr-Wentz/The-Thyroid-Secret/prweb14192245.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 29, 2017 Category: Pharmaceuticals Source Type: news

Brain Aneurysm Foundation Hosts Congressional Advocacy Day to Support...
The Brain Aneurysm Foundation will lead a delegation made up of 100 brain aneurysm survivors, family members of those affected by the disease, advocates and medical professionals from around the...(PRWeb March 29, 2017)Read the full story at http://www.prweb.com/releases/2017/03/prweb14192740.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 29, 2017 Category: Pharmaceuticals Source Type: news

Applied Rigaku Technologies, Inc. Showcases Latest Instrumentation at...
EDXRF technology from Rigaku is featured at the Global Release Liner Industry Conference & Exhibition in Chicago.(PRWeb March 29, 2017)Read the full story at http://www.prweb.com/releases/2017/03/prweb14193610.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 29, 2017 Category: Pharmaceuticals Source Type: news

Recipients of ACEA Bioscience ’s Travel Award Announced for Winter 2017
San Diego-based biotechnology company awards funding to researchers in the fields of immunology and cancer epigenetics/chemotherapy.(PRWeb March 29, 2017)Read the full story at http://www.prweb.com/releases/2017/03/prweb14188669.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 29, 2017 Category: Pharmaceuticals Source Type: news

Colpitts Clinical Trial Travel Is Set to Manage Its 500th Trial
Colpitts Clinical Trial Travel has announced that it will manage travel services for its 500th clinical trial this month. The experience of servicing 500 trials has given Colpitts’ clinical team...(PRWeb March 29, 2017)Read the full story at http://www.prweb.com/releases/2017/03/prweb14192119.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 29, 2017 Category: Pharmaceuticals Source Type: news

Infectex reports positive data from Phase IIb-III trial of SQ109 to treat MDR-TB
Russian biotechnology company Infectex has reported positive results from a Phase IIb-III clinical trial of SQ109 to treat patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). (Source: Drug Development Technology)
Source: Drug Development Technology - March 28, 2017 Category: Pharmaceuticals Source Type: news

Biophytis starts enrolment for SARA-OBS trial of sarconeos in Europe
French biotechnology firm Biophytis has opened its first clinical centres in Europe and started patient enrolment for SARA-OBS clinical trial of sarconeos to treat sarcopenia. (Source: Drug Development Technology)
Source: Drug Development Technology - March 28, 2017 Category: Pharmaceuticals Source Type: news

EMA issues positive opinion for EUSA Pharma's Dinutuximab beta to treat neuroblastoma
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favour of marketing authorisation for EUSA Pharma's antibody ch14.18/CHO, Dinutuximab beta, to treat high-risk neuroblastoma … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 28, 2017 Category: Pharmaceuticals Source Type: news

Paralysed man regains movement via power of thought
Brain implant enables quadriplegic patient to move limb electronically (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 28, 2017 Category: Pharmaceuticals Source Type: news